The Investor Relations website contains information about Standard BioTools Inc.'s business for stockholders, potential investors, and financial analysts.

The meeting has hosted a succession of technology launches, marking the shift from Sanger to next-generation sequencing and, more recently, to spatial and multiomics platforms.

Remarkable advances in high-throughput sequencing have enabled major biological discoveries and clinical applications, but achieving wider distribution and use depends critically on further improvemen...

The company also launched an improved version of the portable low-throughput DNBSeq-E25 platform that incorporates AI base calling for greater speed.

ALT: a group of men are standing around a man in a white shirt and blue jeans .